Randomized, Double-Blind, Placebo-Controlled, Multicentered Trial of the Efficacy of a Single Dose of Live Oral Cholera Vaccine CVD 103-HgR in Preventing Cholera following Challenge with Vibrio cholerae O1 El Tor Inaba Three Months after Vaccination

CVD 103-HgR is a live oral cholera vaccine strain constructed by deleting 94% of the gene for the enzymatically active A subunit of cholera toxin from classical Inaba Vibrio cholerae O1 569B; the strain also contains a mercury resistance gene as an identifying marker. This vaccine was well tolerated...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Infect Immun
المؤلفون الرئيسيون:	Tacket, Carol O., Cohen, Mitchell B., Wasserman, Steven S., Losonsky, Genevieve, Livio, Sofie, Kotloff, Karen, Edelman, Robert, Kaper, James B., Cryz, Stanley J., Giannella, Ralph A., Schiff, Gilbert, Levine, Myron M.
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	American Society for Microbiology (ASM) 1999
الموضوعات:	Microbial Immunity and Vaccines
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC97039/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10569747/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.67.12.6341-6345.1999
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!